TY - JOUR AU - Coley, W. B. PY - 1893 DA - 1893// TI - The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases JO - Am J Med Sci VL - 10 UR - https://doi.org/10.1097/00000441-189305000-00001 DO - 10.1097/00000441-189305000-00001 ID - Coley1893 ER - TY - JOUR AU - Rosenberg, S. A. AU - Yang, J. C. AU - Restifo, N. P. PY - 2004 DA - 2004// TI - Cancer immunotherapy: moving beyond current vaccines JO - Nat Med VL - 10 UR - https://doi.org/10.1038/nm1100 DO - 10.1038/nm1100 ID - Rosenberg2004 ER - TY - JOUR AU - Leach, D. R. AU - Krummel, M. F. AU - Allison, J. P. PY - 1996 DA - 1996// TI - Enhancement of antitumor immunity by CTLA-4 blockade JO - Science VL - 271 UR - https://doi.org/10.1126/science.271.5256.1734 DO - 10.1126/science.271.5256.1734 ID - Leach1996 ER - TY - JOUR AU - Kwon, E. D. AU - Hurwitz, A. A. AU - Foster, B. A. AU - Madias, C. AU - Feldhaus, A. L. AU - Greenberg, N. M. AU - Burg, M. B. AU - Allison, J. P. PY - 1997 DA - 1997// TI - Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer JO - Proc Natl Acad Sci U S A VL - 94 UR - https://doi.org/10.1073/pnas.94.15.8099 DO - 10.1073/pnas.94.15.8099 ID - Kwon1997 ER - TY - JOUR AU - Ishida, Y. AU - Agata, Y. AU - Shibahara, K. AU - Honjo, T. PY - 1992 DA - 1992// TI - Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death JO - EMBO J VL - 11 UR - https://doi.org/10.1002/j.1460-2075.1992.tb05481.x DO - 10.1002/j.1460-2075.1992.tb05481.x ID - Ishida1992 ER - TY - JOUR AU - Freeman, G. J. AU - Long, A. J. AU - Iwai, Y. AU - Bourque, K. AU - Chernova, T. AU - Nishimura, H. AU - Fitz, L. J. AU - Malenkovich, N. AU - Okazaki, T. AU - Byrne, M. C. PY - 2000 DA - 2000// TI - Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation JO - J Exp Med VL - 192 UR - https://doi.org/10.1084/jem.192.7.1027 DO - 10.1084/jem.192.7.1027 ID - Freeman2000 ER - TY - JOUR AU - Iwai, Y. AU - Terawaki, S. AU - Honjo, T. PY - 2005 DA - 2005// TI - PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells JO - Int Immunol VL - 17 UR - https://doi.org/10.1093/intimm/dxh194 DO - 10.1093/intimm/dxh194 ID - Iwai2005 ER - TY - JOUR AU - Baumeister, S. H. AU - Freeman, G. J. AU - Dranoff, G. AU - Sharpe, A. H. PY - 2016 DA - 2016// TI - Coinhibitory pathways in immunotherapy for Cancer JO - Annu Rev Immunol VL - 34 UR - https://doi.org/10.1146/annurev-immunol-032414-112049 DO - 10.1146/annurev-immunol-032414-112049 ID - Baumeister2016 ER - TY - JOUR AU - Liu, Z. AU - Ravindranathan, R. AU - Kalinski, P. AU - Guo, Z. S. AU - Bartlett, D. L. PY - 2017 DA - 2017// TI - Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/ncomms14754 DO - 10.1038/ncomms14754 ID - Liu2017 ER - TY - JOUR AU - Haanen, J. PY - 2017 DA - 2017// TI - Converting cold into hot tumors by combining immunotherapies JO - Cell VL - 170 UR - https://doi.org/10.1016/j.cell.2017.08.031 DO - 10.1016/j.cell.2017.08.031 ID - Haanen2017 ER - TY - JOUR AU - Ribas, A. AU - Dummer, R. AU - Puzanov, I. AU - VanderWalde, A. AU - Andtbacka, R. H. I. AU - Michielin, O. AU - Olszanski, A. J. AU - Malvehy, J. AU - Cebon, J. AU - Fernandez, E. PY - 2017 DA - 2017// TI - Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy JO - Cell VL - 170 UR - https://doi.org/10.1016/j.cell.2017.08.027 DO - 10.1016/j.cell.2017.08.027 ID - Ribas2017 ER - TY - JOUR AU - Chesney, J. AU - Puzanov, I. AU - Collichio, F. AU - Singh, P. AU - Milhem, M. M. AU - Glaspy, J. AU - Hamid, O. AU - Ross, M. AU - Friedlander, P. AU - Garbe, C. PY - 2018 DA - 2018// TI - Randomized, open-label phase II study evaluating the efficacy and safety of Talimogene Laherparepvec in combination with ipilimumab versus ipilimumab alone in patients with advanced, unresectable melanoma JO - J Clin Oncol VL - 36 UR - https://doi.org/10.1200/JCO.2017.73.7379 DO - 10.1200/JCO.2017.73.7379 ID - Chesney2018 ER - TY - JOUR AU - June, C. H. AU - O'Connor, R. S. AU - Kawalekar, O. U. AU - Ghassemi, S. AU - Milone, M. C. PY - 2018 DA - 2018// TI - CAR T cell immunotherapy for human cancer JO - Science VL - 359 UR - https://doi.org/10.1126/science.aar6711 DO - 10.1126/science.aar6711 ID - June2018 ER - TY - JOUR AU - Rosenberg, S. A. AU - Restifo, N. P. PY - 2015 DA - 2015// TI - Adoptive cell transfer as personalized immunotherapy for human cancer JO - Science VL - 348 UR - https://doi.org/10.1126/science.aaa4967 DO - 10.1126/science.aaa4967 ID - Rosenberg2015 ER - TY - JOUR AU - Ott, P. A. AU - Hu, Z. AU - Keskin, D. B. AU - Shukla, S. A. AU - Sun, J. AU - Bozym, D. J. AU - Zhang, W. AU - Luoma, A. AU - Giobbie-Hurder, A. AU - Peter, L. PY - 2017 DA - 2017// TI - An immunogenic personal neoantigen vaccine for patients with melanoma JO - Nature VL - 547 UR - https://doi.org/10.1038/nature22991 DO - 10.1038/nature22991 ID - Ott2017 ER - TY - JOUR AU - Sahin, U. AU - Derhovanessian, E. AU - Miller, M. AU - Kloke, B. P. AU - Simon, P. AU - Lower, M. AU - Bukur, V. AU - Tadmor, A. D. AU - Luxemburger, U. AU - Schrors, B. PY - 2017 DA - 2017// TI - Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer JO - Nature VL - 547 UR - https://doi.org/10.1038/nature23003 DO - 10.1038/nature23003 ID - Sahin2017 ER -